ヒト肝臓モデルの世界市場レポート 2024

ヒト肝臓モデルの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には12.9%の年間複合成長率（CAGR）で37億9,000万米ドルに成長すると予想されます。予測期間で予想される成長は、AIと機械学習の統合、患者由来の肝臓モデルの開発、生物工学の画期的な進歩、医薬品の安全性と毒性試験の要件、仮想臨床試験の採用に起因すると考えられます。予測期間中に予想される主な動向には、多臓器モデルの統合、3Dバイオプリンティングの革新、ハイスループットスクリーニング能力の向上、血管新生と血流の改善、倫理および規制遵守への重点の強化などが含まれます。

ヒト肝臓モデル市場の成長は、肝疾患の発生率の増加によって促進されると予想されます。肝疾患には、肝臓の適切な機能に影響を与えるさまざまな障害が含まれます。 ヒト肝臓モデルに関連する新たな調査分野は、肝臓疾患の理解を深め、医薬品開発を改善する可能性を秘めています。その結果、肝疾患の増加がヒト肝臓モデル市場の拡大を促進しています。たとえば、2022年9月、Caner Australiaは、2022年にオーストラリアで新たに肝臓がんと診断された症例が約2,905人であると報告し、肝臓関連の健康上の懸念に対処する重要性を強調しました。肝疾患の有病率の上昇は、医学調査と治療戦略の進歩におけるヒト肝臓モデルの重要な役割を浮き彫りにしています。

ヒト肝臓モデル市場の成長は、臨床試験数の増加によってさらに促進されることが予想されます。臨床試験は、ヒトにおける医療介入、治療法、薬物の安全性と有効性を評価するために不可欠であり、医薬品開発の文脈で薬物代謝をシミュレートし、肝毒性を評価するためにヒト肝臓モデルを頻繁に使用します。 2023年 5月の時点で、世界中で452,604件の臨床試験が登録されており、以前の数から大幅に増加しています。臨床試験の急増は、堅牢な調査実践を促進し、創薬イニシアチブを前進させる上で、ヒト肝臓モデルに対する需要が高まっていることを浮き彫りにしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のヒト肝臓モデル市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 肝臓オルガノイド
• レバーオンアチップ
• 2Dモデル
• 動物モデル
• 3Dバイオプリンティング
• 世界のヒト肝臓モデル市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 教育的
• 創薬
• その他の用途
• 世界のヒト肝臓モデル市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 研究機関
• 製薬会社
• その他のエンドユーザー

第7章 地域および国の分析

• 世界のヒト肝臓モデル市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のヒト肝臓モデル市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヒト肝臓モデル市場の競合情勢
• ヒト肝臓モデル市場の企業プロファイル
  • Corning Incorporated
  • EISCO Scientific LLC
  • BioIVT LLC
  • Cyprotex plc
  • Emulate Inc.

第31章 その他の大手および革新的な企業

• Cellink AB
• Strand Life Sciences Pvt Ltd.
• Nortis Inc.
• InSphero AG
• CN Bio Innovations Ltd.
• TissUse GmbH
• Ascendance Biotechnology Inc.
• HemoShear Therapeutics Inc.
• Cyfuse Biomedical KK
• Cyfuse Biomedical
• MIMETAS BV
• Bio Innovations
• Biopredic International Sarl
• ZenBio
• Hurel Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

The human liver model represents a dual-lobed model of the human liver, primarily responsible for filtering blood from the digestive tract. It is utilized to illustrate and assess the toxic effects of drug candidates on the liver.

The primary product types of human liver models include liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting. Liver organoids are 3D structures generated from stem cells that self-organize through mechanisms similar to those in vivo. These models find applications in education, drug discovery, and other fields, and are employed by research institutes, pharmaceutical companies, and other entities.

The human liver model market research report is one of a series of new reports from The Business Research Company that provides human liver model market statistics, including human liver model industry global market size, regional shares, competitors with a human liver model market share, detailed human liver model market segments, market trends and opportunities, and any further data you may need to thrive in the human liver model industry. This human liver model market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human liver model market size has grown rapidly in recent years. It will grow from $2.07 billion in 2023 to $2.33 billion in 2024 at a compound annual growth rate (CAGR) of 12.7%. The growth observed in the historical period can be attributed to the needs in drug development, advancements in biotechnology, alternatives to animal testing, the increasing prevalence of liver diseases, and regulatory requirements.

The human liver model market size is expected to see rapid growth in the next few years. It will grow to $3.79 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The anticipated growth in the forecast period can be attributed to the integration of AI and machine learning, the development of patient-derived liver models, breakthroughs in bioengineering, requirements for drug safety and toxicity testing, and the adoption of virtual clinical trials. Major trends expected in the forecast period include the integration of multi-organ models, innovations in 3D bioprinting, increased capability for high-throughput screening, improvements in vascularization and blood flow, and a heightened focus on ethical and regulatory compliance.

The growth of the human liver model market is anticipated to be driven by the increasing incidence of liver disease. Liver disease encompasses various disorders that affect the proper functioning of the liver. The emerging area of research involving human liver models holds the potential to enhance understanding of liver diseases and improve drug development. Consequently, the escalating cases of liver diseases are fostering the expansion of the human liver model market. For instance, in September 2022, Caner Australia reported approximately 2,905 new cases of liver cancer diagnosed in Australia in 2022, highlighting the significance of addressing liver-related health concerns. The rising prevalence of liver disease underscores the crucial role of human liver models in advancing medical research and therapeutic strategies.

The growth of the human liver model market is further expected to be propelled by the increasing number of clinical trials. Clinical trials, essential for evaluating the safety and efficacy of medical interventions, treatments, or drugs in humans, frequently employ human liver models to simulate drug metabolism and assess hepatotoxicity in the context of pharmaceutical development. As of May 2023, there are 452,604 registered clinical trials globally, signifying a substantial increase from previous counts. The surge in clinical trials emphasizes the growing demand for human liver models in facilitating robust research practices and advancing drug discovery initiatives.

A prominent trend in the human liver model market is the focus on product innovation by major companies. Companies operating in this market are actively engaged in developing innovative products to enhance their market positioning. In April 2023, LifeNet Health Life Sciences introduced TruVivo, a groundbreaking liver system composed entirely of human cells. TruVivo represents a 2D+ solution that combines the robust data associated with 3D models with the flexibility and simplicity of a 2D model, offering a significant advancement in liver research and drug development.

Major players in the human liver model market are directing their efforts toward the development of advanced systems, particularly single-organ higher throughput (HT) systems. These innovative systems aim to improve the adoption of predictive human liver models and provide a competitive advantage. For instance, in February 2023, UK-based organ-on-a-chip company CN Bio launched PhysioMimix with Liver-48 plate, a single-organ higher throughput (HT) system designed to overcome challenges in the adoption of predictive human liver models for drug discovery. The Liver-48 plate, a multi-chip consumable, facilitates larger-scale comparative studies on drug disposition, efficacy, and safety.

In September 2021, Sweden-based life science company BICO acquired HUREL Corporation for $2.5 million. This acquisition positions BICO to expand its offerings with liver co-culture models and assays, catering to the diverse needs of customers. HUREL Corporation, based in the United States, specializes in providing microfluidic solutions, cell culture technologies, and liver models.

Major companies operating in the human liver model market report are Corning Incorporated, EISCO Scientific LLC, BioIVT LLC, Cyprotex PLC, Emulate Inc., Cellink AB, Strand Life Sciences Pvt Ltd., Nortis Inc., InSphero AG, CN Bio Innovations Ltd., TissUse GmbH, Ascendance Biotechnology Inc., HemoShear Therapeutics Inc., Cyfuse Biomedical KK, Cyfuse Biomedical, MIMETAS BV, Bio Innovations, Biopredic International Sarl, ZenBio, Hurel Corporation, Regenovo, Pandorum, Organovo Holdings Inc., BICO Group, Hepregen Corporation, Kirkstall Ltd., HepaLife Technologies Inc., Cellaion SA.

North America was the largest region in the human liver model market in 2023. The regions covered in the human liver model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the human liver model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human liver model market consists of sales of 3B scientific liver and prime baker fiber liver model. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Liver Model Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human liver model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human liver model ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human liver model market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Liver Organoids; Liver-On-A-Chip; 2D Models; Animal Models; 3D Bioprinting
• 2) By Application: Educational; Drug Discovery; Other Applications
• 3) By End Users: Research Institutes; Pharmaceutical Companies; Other End Users
• Companies Mentioned: Corning Incorporated; EISCO Scientific LLC; BioIVT LLC; Cyprotex plc; Emulate Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Liver Model Market Characteristics

3. Human Liver Model Market Trends And Strategies

4. Human Liver Model Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Human Liver Model Market Size and Growth

• 5.1. Global Human Liver Model Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Human Liver Model Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Human Liver Model Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Human Liver Model Market Segmentation

• 6.1. Global Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Liver Organoids
• Liver-On-A-Chip
• 2D Models
• Animal Models
• 3D Bioprinting
• 6.2. Global Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Educational
• Drug Discovery
• Other Applications
• 6.3. Global Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Research Institutes
• Pharmaceutical Companies
• Other End Users

7. Human Liver Model Market Regional And Country Analysis

• 7.1. Global Human Liver Model Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Human Liver Model Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Human Liver Model Market

• 8.1. Asia-Pacific Human Liver Model Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Human Liver Model Market

• 9.1. China Human Liver Model Market Overview
• 9.2. China Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Human Liver Model Market

• 10.1. India Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Human Liver Model Market

• 11.1. Japan Human Liver Model Market Overview
• 11.2. Japan Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Human Liver Model Market

• 12.1. Australia Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Human Liver Model Market

• 13.1. Indonesia Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Human Liver Model Market

• 14.1. South Korea Human Liver Model Market Overview
• 14.2. South Korea Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Human Liver Model Market

• 15.1. Western Europe Human Liver Model Market Overview
• 15.2. Western Europe Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Human Liver Model Market

• 16.1. UK Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Human Liver Model Market

• 17.1. Germany Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Human Liver Model Market

• 18.1. France Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Human Liver Model Market

• 19.1. Italy Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Human Liver Model Market

• 20.1. Spain Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Human Liver Model Market

• 21.1. Eastern Europe Human Liver Model Market Overview
• 21.2. Eastern Europe Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Human Liver Model Market

• 22.1. Russia Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Human Liver Model Market

• 23.1. North America Human Liver Model Market Overview
• 23.2. North America Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Human Liver Model Market

• 24.1. USA Human Liver Model Market Overview
• 24.2. USA Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Human Liver Model Market

• 25.1. Canada Human Liver Model Market Overview
• 25.2. Canada Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Human Liver Model Market

• 26.1. South America Human Liver Model Market Overview
• 26.2. South America Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Human Liver Model Market

• 27.1. Brazil Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Human Liver Model Market

• 28.1. Middle East Human Liver Model Market Overview
• 28.2. Middle East Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Human Liver Model Market

• 29.1. Africa Human Liver Model Market Overview
• 29.2. Africa Human Liver Model Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Human Liver Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Human Liver Model Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Human Liver Model Market Competitive Landscape And Company Profiles

• 30.1. Human Liver Model Market Competitive Landscape
• 30.2. Human Liver Model Market Company Profiles
  • 30.2.1. Corning Incorporated
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. EISCO Scientific LLC
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. BioIVT LLC
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Cyprotex plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Emulate Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Human Liver Model Market Other Major And Innovative Companies

• 31.1. Cellink AB
• 31.2. Strand Life Sciences Pvt Ltd.
• 31.3. Nortis Inc.
• 31.4. InSphero AG
• 31.5. CN Bio Innovations Ltd.
• 31.6. TissUse GmbH
• 31.7. Ascendance Biotechnology Inc.
• 31.8. HemoShear Therapeutics Inc.
• 31.9. Cyfuse Biomedical KK
• 31.10. Cyfuse Biomedical
• 31.11. MIMETAS BV
• 31.12. Bio Innovations
• 31.13. Biopredic International Sarl
• 31.14. ZenBio
• 31.15. Hurel Corporation

32. Global Human Liver Model Market Competitive Benchmarking

33. Global Human Liver Model Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Human Liver Model Market

35. Human Liver Model Market Future Outlook and Potential Analysis

• 35.1 Human Liver Model Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Human Liver Model Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Human Liver Model Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer